Evidence map›Paper›PMID 42733884›Full record

ArticleOpen respiratory archives

Can a Multidisciplinary Team Change the Course of Chronic Thromboembolic Pulmonary Hypertension? Changes in Time to Diagnosis After PERT Implementation.

Matías Almeida Souto, Milagros Báez, Marcella Perri, Nazareno Zelaya de León, Federico Devetter, Christian Smith, Lorena Maldonado, Julio Chertcoff, Alejandro Salvado, Martín Bosio

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open respiratory archives. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matías Almeida SoutoDepartment of Pulmonology, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Milagros BáezDepartment of Internal Medicine, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Marcella PerriDepartment of Pulmonology, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Nazareno Zelaya de LeónDepartment of Pulmonology, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Federico DevetterDepartment of Cardiology, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Christian SmithDepartment of Cardiology, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Lorena MaldonadoDepartment of Pulmonology, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Julio ChertcoffDepartment of Pulmonology, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Alejandro SalvadoDepartment of Pulmonology, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Martín BosioDepartment of Pulmonology, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially curable form of pulmonary hypertension, yet diagnostic delay remains a major barrier to timely treatment. Pulmonary embolism response teams (PERT) have emerged as a strategy to optimize follow-up after acute pulmonary embolism (APE), but local evidence on their impact on CTEPH diagnostic timing is scant. We conducted a single-center, retrospective cohort study comparing patients diagnosed with CTEPH before and after PERT implementation in a general hospital in Argentina. Among 29 patients, those diagnosed after PERT implementation had a significantly shorter time from APE to CTEPH diagnosis (median 43 vs. 256 weeks,

Indexed as

Chronic thromboembolic pulmonary hypertensionDiagnostic delayPulmonary embolismPulmonary embolism response teamPulmonary hypertension

Identifiers

PMID42733884
PMCPMC13571710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.